The data shows the top 15 drugs for Medicare spent the most on, in the United States during 2015. On Harvoni, a hepatitis C drug, Medicare spent more than seven billion USD during that year.
Harvoni | 7.03 |
Lantus Solostar | 4.36 |
Crestor | 2.88 |
Advair Diskus | 2.27 |
Spiriva | 2.19 |
Januvia | 2.13 |
Revlimid | 2.08 |
Nexium | 2.01 |
Eylea | 1.81 |
Lyrica | 1.77 |
Humira | 1.66 |
Abilify | 1.57 |
Rituxan | 1.56 |
Xarelto | 1.52 |
Enbrel | 1.39 |